IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NPS Pharmaceuticals Inc

CUSIP: 62936P903 | 6 institutional holders

Quarters

Q4 2014Q3 2014Q2 2014Q1 2014Q4 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile